[{"indications": "Indications\u00a0prostate cancer", "name": "ESTRAMUSTINE PHOSPHATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "8 Malignant disease and immunosuppression", "8.1 Cytotoxic drugs", "8.1.1 Alkylating drugs"], "cautions": "Cautions\u00a0see section 8.1; congestive heart failure; diabetes; hypertension; epilepsy; hypercalcaemia; avoid in acute porphyria (but see section 9.8.2); interactions: Appendix 1\r\n(estramustine)", "side-effects": "Side-effects\u00a0see section 8.1; also diarrhoea; congestive heart\r\nfailure, ischaemic heart disease, myocardial infarction; oedema (rarely\r\nangioneurotic) impotence, gynaecomastia; altered liver function", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4687.htm", "doses": ["0.14\u20131.4\u00a0g daily in divided doses (usual initial dose\r\n560\u2013840\u00a0mg daily)", "Each dose should be taken not less\r\nthan 1 hour before or 2 hours after meals and should not be taken\r\nwith dairy products"]}]